Physiological CAR T

This physiological CAR consists of an antigen receptor and a CD3? intracellular signaling domain with/without a TM and a spacer region, which can also be engineered into immune cells to target its ligands expressed on tumor cells. This approach increases the ability of T cells to recognize tumor associated targets and eliminate cancer cells, which has already been applied in the field of adoptive immunotherapy.